Revvity Developing Automated Platform for Tuberculosis Testing
Revvity is developing the T-SPOT A201, an automated platform for latent tuberculosis testing in high-volume labs, with planned launch in 2027 pending regulatory approval.
Category: Infectious Diseases
Infectious Diseases
Latest
Infectious Diseases
Latest
Stanford Blood Center Launches Infectious Disease Testing for Organ and Tissue Donors
The new service supports transplantation medicine for 13 million people across Northern California and Northern Nevada.
Infectious Diseases
Latest
FDA Clears Rapid PCR System for Rapid Respiratory Virus Testing
The system simultaneously detects RSV, influenza A and B, and SARS-CoV-2 from a nasal swab in under 10 minutes.
Emerging & Zoonotic Diseases
Latest
Molecular Platform Shows Promise for Detecting Asymptomatic Malaria Cases
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
Flu & Respiratory Infections
Latest
CE Mark Granted for Rapid Bacterial vs Viral Infection Test
The high-throughput host-response assay provides results in approximately 20 minutes to help guide treatment decisions and antimicrobial stewardship.
Gastrointestinal Infections
Latest
FDA Clears Cepheid’s Multiplex GI Pathogen Panel
The PCR test detects 11 bacterial, viral, and parasitic pathogens from a stool sample in approximately 74 minutes.
Sexually Transmitted Diseases
Latest
Blood Test May Improve Risk Assessment for HPV-Related Throat Cancer
Research identifies how circulating tumor DNA can inform personalized treatment and surveillance strategies.